Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 5
2021 6
2022 1
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Hot topics in hepatocellular carcinoma.
Ielasi L, Goio E, Tovoli F. Ielasi L, et al. Transl Cancer Res. 2019 Apr;8(Suppl 3):S216-S218. doi: 10.21037/tcr.2018.08.01. Transl Cancer Res. 2019. PMID: 35117101 Free PMC article. No abstract available.
Donafenib in hepatocellular carcinoma.
Chen R, Ielasi L, di Carlo A, Tovoli F. Chen R, et al. Among authors: ielasi l. Drugs Today (Barc). 2023 Feb;59(2):83-90. doi: 10.1358/dot.2023.59.2.3507751. Drugs Today (Barc). 2023. PMID: 36811408 Review.
Treatment of Combined Hepatocellular and Cholangiocarcinoma.
Leoni S, Sansone V, Lorenzo S, Ielasi L, Tovoli F, Renzulli M, Golfieri R, Spinelli D, Piscaglia F. Leoni S, et al. Among authors: ielasi l. Cancers (Basel). 2020 Mar 26;12(4):794. doi: 10.3390/cancers12040794. Cancers (Basel). 2020. PMID: 32224916 Free PMC article. Review.
Experience with regorafenib in the treatment of hepatocellular carcinoma.
Granito A, Forgione A, Marinelli S, Renzulli M, Ielasi L, Sansone V, Benevento F, Piscaglia F, Tovoli F. Granito A, et al. Among authors: ielasi l. Therap Adv Gastroenterol. 2021 May 28;14:17562848211016959. doi: 10.1177/17562848211016959. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34104211 Free PMC article. Review.
TKIs in combination with immunotherapy for hepatocellular carcinoma.
Stefanini B, Ielasi L, Chen R, Abbati C, Tonnini M, Tovoli F, Granito A. Stefanini B, et al. Among authors: ielasi l. Expert Rev Anticancer Ther. 2023 Mar;23(3):279-291. doi: 10.1080/14737140.2023.2181162. Epub 2023 Feb 26. Expert Rev Anticancer Ther. 2023. PMID: 36794716 Review.
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib.
Sansone V, Tovoli F, Casadei-Gardini A, Di Costanzo GG, Magini G, Sacco R, Pressiani T, Trevisani F, Rimini M, Tortora R, Nardi E, Ielasi L, Piscaglia F, Granito A. Sansone V, et al. Among authors: ielasi l. Clin Transl Gastroenterol. 2021 Jan 14;12(1):e00286. doi: 10.14309/ctg.0000000000000286. Clin Transl Gastroenterol. 2021. PMID: 33443944 Free PMC article.
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.
Orsi G, Tovoli F, Dadduzio V, Vivaldi C, Brunetti O, Ielasi L, Conti F, Rovesti G, Gramantieri L, Rizzato MD, Pecora I, Argentiero A, Teglia F, Lonardi S, Salani F, Granito A, Zagonel V, Marisi G, Cabibbo G, Foschi FG, Benevento F, Cucchetti A, Piscaglia F, Cascinu S, Scartozzi M, Casadei-Gardini A. Orsi G, et al. Among authors: ielasi l. Target Oncol. 2020 Dec;15(6):773-785. doi: 10.1007/s11523-020-00757-3. Target Oncol. 2020. PMID: 33044683
19 results